SEC Form 4 · accession 0001192482-15-000391
COLLEGIUM PHARMACEUTICAL, INC · COLL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gino Santini
Director
Period of report
Sep 10, 2015
Accepted (ET)
Sep 14, 2015 · 4:03 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001267565
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Purchase)F1 | $13.45 | Sep 10, 2015 | A | 15,000 | A | — | Sep 10, 2025 | Common Stock | 15,000 | 15,000 | D |
Explanation of responses
- F1The options vest and become exercisable over a 4-year period commencing on August 4, 2015. Twenty-five percent (25%) of the options vest and become exercisable on August 4, 2016, and the balance of the shares vest in equal monthly installments (rounded up to the nearest whole option) over the remaining three years.